The size of the Hip replacement devices Market in the Asia Pacific was worth USD 1.08 billion in 2021 and estimated to be growing at a CAGR of 3.1%, to reach USD 1.26 billion by 2026.
A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may get damaged due to overuse, trauma, or certain conditions, such as rheumatoid arthritis, tumors, and so on. This may lead to degenerative changes within the hip which can lead to osteoarthritis.
The steady growth of the hip replacement implant market is attributed to rising geriatric population, increasing incidences of accidents, and rising prevalence of osteoarthritis. Technological advancements in the field of artificial hip implant resulting in new and innovative products such as mobile bearing hip implant and various material combination implants have increased the mobility and flexibility of the leg. These innovations have also reduced the side effects for artificial implants, thereby augmenting their demand. However, price pressure, risk of complications after surgery, and waiting time for surgery in hospitals are some of the major hindering factors.
This research report on the Asia Pacific Hip Replacement Devices Market has been segmented and sub-segmented into the following categories:
By product:
By Material:
By End-user:
By Country:
On the basis of geography, Asia Pacific is expected to register a significant growth.
Promising companies dominating the Asia Pacific hip replacement market are B. Braun Melsungen AG, Exactech, Inc., DJO Global, Inc., Johnson & Johnson, MicroPort Scientific Corporation, OMNIlife science, Inc., Smith & Nephew, Zimmer Biomet Holdings, Inc., and Stryker Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Total
5.1.3 Fixed
5.1.4 Mobile bearing
5.1.5 Partial hip replacement
5.1.6 Hip resurfacing
5.1.7 Revision hip replacement
5.1.8 Y-o-Y Growth Analysis, By Product
5.1.9 Market Attractiveness Analysis, By Product
5.1.10 Market Share Analysis, By Product
5.2 Material
5.2.1 Introduction
5.2.2 Metal on metal
5.2.3 Metal on polyethylene
5.2.4 Ceramic on metal
5.2.5 Ceramic on polyethylene
5.2.6 Ceramic on ceramic
5.2.7 Y-o-Y Growth Analysis, By material
5.2.8 Market Attractiveness Analysis, By material
5.2.9 Market Share Analysis, By material
5.3 End user
5.3.1 Introduction
5.3.2 Ambulatory surgical centres
5.3.3 Hospitals
5.3.4 Orthopaedic clinics
5.3.5 Y-o-Y Growth Analysis, By end user
5.3.6 Market Attractiveness Analysis, By end user
5.3.7 Market Share Analysis, By end user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By material
6.1.3.4 By end user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By material
6.1.4.4 By end user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By material
6.1.5.4 By end user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 B. Braun Melsungen AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Exactech, Inc.
8.3 DJO Global, Inc.
8.4 Johnson & Johnson
8.5 MicroPort Scientific Corporation
8.6 OMNIlife science, Inc.
8.7 Smith & Nephew
8.8 Zimmer Biomet Holdings, Inc.
8.9 Cytori Therapeutics
8.10 Stryker Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
